| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Xylometazoline | Xylometazoline EP Impurity A | VE009719 | View CAS 94266-17-8 |
Xylometazoline Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Xylometazoline | Xylometazoline EP Impurity A | VE009719 | View CAS 94266-17-8 |
| Catalogue No. | VE009719 |
| CAS No. | 94266-17-8 |
| Molecular Formula | C16H26N2O |
| Molecular Weight | 262.39 g/mol |
| Parent drug | Xylometazoline |
| IUPAC Name | N-(2-Aminoethyl)-2-[4-(1, 1-dimethylethyl)-2, 6-dimethylphenyl]acetamide |
| Synonyms | N/A |
| References | Graf, C., Bernkop-Schnürch, A., Egyed, A., Koller, C., Prieschl-Grassauer, E., & Morokutti-Kurz, M. (2018). Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis. International Journal of General Medicine, Volume 11, 275–283. https://doi.org/10.2147/ijgm.s167123 |
| Status | In-stock |
| ListName | Xylometazoline EP Impurity A |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
